Transgenic animals

Transgenic animals

Transgenic animals are animals that have been cloned. The medical and biotechnological uses of animal cloning are almost innumerable, as many diseases have been eradicated thanks to the production of these transgenic animals.

Transgenic animals development

Since the discovery of the molecular structure of DNA by Watson and Crick in 1953, molecular biology research has gained momentum. Molecular biology technology combines techniques and expertise from biochemistry, genetics, cell biology, developmental biology, and microbiology.

since Watson and Crick’s discovery, there have been breakthroughs in:

  • recombinant DNA (artificially-produced DNA)
  • genetic cloning
  • genomic mapping

The underlying principle in the production of transgenic animals is the introduction of a foreign gene or genes into an animal (the inserted genes are called transgenes). The foreign genes “must be transmitted through the germ line, so that every cell, including germ cells, of the animal contain the same modified genetic material.”26 (Germ cells are cells whose function is to transmit genes to an organism’s offspring.)

Gene transfer by microinjection is the predominant method used to produce transgenic farm animals. Since the insertion of DNA results in a random process, transgenic animals are mated to ensure that their offspring acquire the desired transgene. However, the success rate of producing transgenic animals individually by these methods is very low and it may be more efficient to use cloning techniques to increase their numbers. For example, gene transfer studies revealed that only 0.6% of transgenic pigs were born with a desired gene after 7,000 eggs were injected with a specific transgene.

The ability to produce transgenic animals is reliant on a number of components. One of the first things needed to generate transgenic animals is the ability to transfer embryos. The first successful transfer of embryos was achieved by Walter Heape in Angora rabbits in 1891. Another important component is the ability to manipulate the embryo. In vitro manipulation of embryos in mice was first reported in the 1940s using a culture system. What is also vital is the ability to manipulate eggs. This was made possible through the efforts of Ralph Brinster, attached to the University of Pennsylvania, who in 1963 devised a reliable system to culture eggs, and that of Teh Ping Lin, based at the California School of Medicine, who in 1966 outlined a technique to micro-inject fertilised mouse eggs which enabled the accurate insertion of foreign DNA.

The first genetic modification of animals was reported in 1974 by the virologist Rudolph Jaenisch, then at the Salk Institute, and the mouse embryologist Beatrice Mintz at Fox Chase Cancer Center. They demonstrated the feasibility of modifying genes in mice by injecting the SV40 virus into early-stage mouse embryos. The resulting mice carried the modified gene in all their tissues. In 1976, Jaenisch reported that the Moloney Murine Leukemia Virus could also be passed on to offspring by infecting an embryo. Four years later, in 1980, Jon Gordon and George Scango together with Frank Ruddle, announced the birth of a mouse born with genetic material they had inserted into newly fertilised mouse eggs. By 1981 other scientists had reported the successful implantation of foreign DNA into mice, thereby altering the genetic makeup of the animals. This included Mintz with Tim Stewart and Erwin Wagner at the Fox Chase Cancer Center in Philadelphia; Brinster and Richard Palmiter at the University of Washington, Seattle; and Frank Costantini and Elizabeth Lacy at Oxford University.

Such work laid the basis for the creation of transgenic mice genetically modified to inherit particular forms of cancer. These mice were generated as a laboratory tool to better understand the onset and progression of cancer. The advantage of such mice is that they provide a model which closely mimics the human body. The mice not only provide a means to gain greater insight into cancer but also to test experimental drugs.


Applications of transgenic animals

Transgenic animals are animals (most commonly mice) that have had a foreign gene deliberately inserted into their genome. Such animals are most commonly created by the microinjection of DNA into the pronuclei of a fertilised egg which is subsequently implanted into the oviduct of a pseudopregnant surrogate mother. This results in the recipient animal giving birth to genetically modified offspring. The progeny are then bred with other transgenic offspring to establish a transgenic line. Transgenic animals can also be created by inserting DNA into embryonic stem cells which are then micro-injected into an embryo which has developed for five or six days after fertilisation, or infecting an embryo with viruses that carry a DNA of interest. This final method is commonly used to manipulate a single gene, in most cases this involves removing or ‘knocking out’ a target gene. The end result is what is known as a ‘knockout’ animal.

Since the mid-1980s transgenic mice have become a key model for investigating disease. Mice are the model of choice not only because there is extensive analysis of its completed genome sequence, but its genome is similar to the human. Moreover, physiologic and behavioural tests performed on mice can be extrapolated directly to human disease. Robust and sophisticated techniques are also easily available for the generic manipulation of mouse cells and embryos. Another advantage of mice is the fact that they have a short reproduction cycle. Other transgenic species, such as pig, sheep and rats are also used, but their use in pharmaceutical research has so far been limited due to technical constraints. Recent technological advances, however, are laying the foundation for wider adoption of the transgenic rat.

Transgenic rodents play a number of critical roles in drug discovery and development. Importantly, they enable scientists to study the function of specific genes at the level of the whole organism which has enhanced the study of physiology and disease biology and facilitated the identification of new drug targets. Due to their similarity in physiology and gene function between humans and rodents, transgenic rodents can be developed to mimic human disease. Indeed, an array of transgenic mice models have been produced for this purpose. Mice are being used as models, for example, to study obesity, heart disease, diabetes, arthritis, substance abuse, anxiety, ageing, Alzheimer’s disease and Parkinson’s disease. They are also used to study different forms of cancer. In addition, transgenic pigs are being investigated as a source of organs for transplants, which if proven clinically safe could overcome some of the severe donor organ shortages. The development of transgenic animals has recently been transformed by the emergence of the new gene editing tool CRISPR which greatly reduced the number of steps involved in the creation of transgenic animals, making the whole process much faster and less costly.

APPSC GROUP 1 Notes brings Prelims and Mains programs for APPSC GROUP 1 Prelims and APPSC GROUP 1 Mains Exam preparation. Various Programs initiated by APPSC GROUP 1 Notes are as follows:- For any doubt, Just leave us a Chat or Fill us a querry––